Interpretation and Presentation of Drug Safety Data

This workshop presents a sound general approach to the evaluation of adverse event and laboratory safety data for the purposes of writing clinical study reports and Common Technical Document submissions. Strategies for identifying and reporting the key safety data without overlooking potentially important things will be explained. The best ways to present these data in order to make the job of the regulatory reviewer as efficient as possible will also be explained.


back